#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital absence of bile ducts Blood iron increased Medulloblastoma recurrent Mantle cell lymphoma recurrent Angiosarcoma recurrent Stevens-Johnson syndrome Primitive neuroectodermal tumour Warm autoimmune haemolytic anaemia Angiosarcoma non-metastatic Acromegaly Gastrooesophageal cancer Neutropenia Angiosarcoma metastatic Rosai-Dorfman syndrome Chronic myeloid leukaemia More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranous – Trials in Disease Immunodeficiency congenital – Basic Information Mantle cell lymphoma stage III – Trials in Disease Angiosarcoma non-metastatic – Trials in Disease Rosai-Dorfman syndrome Cystic fibrosis lung – Basic Information Mantle cell lymphoma – Life with Disease Systemic sclerosis pulmonary Waldenstrom’s macroglobulinaemia recurrent – Treatment Toxic epidermal necrolysis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Immunglobulin Caplacizumab Fosphenytoin Sodium Yttrium-90 Fluticasone Furoate Ozanimod Levothyroxine Sodium Anidulafungin Elafibranor Satralizumab AAV9-CTNT-COBAG3 Ligelizumab Tetrahydrouridine Ibuprofen Arginine Nacystelyn Magnesium Citrate A/(H3N2)-LIKE VIRUS ANTIGEN Ivabradine Sar-443579 Naproxen More therapies…

    Learn about Your Condition

    Fatty acid oxidation disorder Staphylococcal bacteraemia Renal injury Double hit lymphoma Intracranial calcification Back pain Infant sedation Dupuytren's contracture Ebola disease Erythema migrans Albuminuria Hepatic angiosarcoma Henoch-Schonlein purpura Dermatomyositis Primary adrenal insufficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Sodium Oxybate for Reducing Alcohol Consumption in Patients with Alcohol Addiction

    Recruiting

    3 1 1
    Investigated Drugs:
    • Sodium Oxybate
    France Italy Poland

  • Study of Pemigatinib and Retifanlimab for Patients with Advanced Dedifferentiated Liposarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Dedifferentiated liposarcoma
    • Liposarcoma
    • Liposarcoma metastatic
    Investigated Drugs:
    • Retifanlimab
    • Pemigatinib
    Denmark Norway Sweden

  • Study on the Long-term Safety and Tolerability of Azetukalner for Patients with Epilepsy, Including Focal-onset and Primary Generalized Tonic-Clonic Seizures

    Recruiting

    3 1 1
    Investigated Drugs:
    • Azetukalner
    Austria Belgium Bulgaria Croatia Czechia Finland +10

  • Study on the Safety and Effectiveness of Dupilumab for Adults and Adolescents with Eosinophilic Gastritis and Eosinophilic Duodenitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Eosinophilic gastritis
    Investigated Drugs:
    • Dupilumab
    France Italy Poland

  • Study on Reducing Immunosuppressive Drugs in Adults with Psoriatic Arthritis: Methotrexate Disodium, Abatacept, and Certolizumab Pegol

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Secukinumab
    • Certolizumab Pegol
    • Methotrexate Disodium
    Germany Italy

  • Study of Abemaciclib and Letrozole for Patients with Estrogen Receptor Positive Low-Grade Serous Ovarian Cancer and Adult-Type Granulosa Cell Tumor

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Abemaciclib
    • Letrozole
    Belgium France The Netherlands
Previous Page
1 … 535 536 537 538 539 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!